Cutaneous lymphoid hyperplasia
Cutaneous lymphoid hyperplasia |
Classification and external resources |
ICD-10 |
L98.8 (ILDS L98.812) |
MeSH |
D019310 |
Cutaneous lymphoid hyperplasia (also known as "borrelial lymphocytoma,"[1] "Lymphadenosis benigna cutis," "Lymphocytoma cutis," "Pseudolymphoma," "Pseudolymphoma of Spiegler and Fendt,"[1] "Sarcoidosis of Spiegler and Fendt,"[1] "Spiegler–Fendt lymphoid hyperplasia,"[1] and "Spiegler–Fendt sarcoid") refers to a groups of benign cutaneous disorders characterized by collections of lymphocytes, macrophages, and dendritic cells in the skin.
[2]:725 Conditions included in this groups are:[2]:725
See also
References
- ^ a b c d Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.
- ^ a b James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
|
|
|
By development/
marker
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
see immunoproliferative immunoglobulin disorders
|
|
|
By infection
|
|
|
|
|
|
|
|
|
By development/
marker
|
|
|
|
|
|
|
|
|
By infection
|
|
|
|
|
|
|
T or NK
|
|
|
|
Lymphoid+myeloid
|
|
|
|
|
|
|
Cutaneous lymphoid hyperplasia |
|
|
|
cell/phys/auag/auab/comp, igrc
|
|
|
|
|
|